Template:PDB Gallery/7276

• 1bm7: HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-3-(TRIFLUOROMETHYL)PHENYL AMINO BENZOIC ACID)

  1bm7: HUMAN TRANSTHYRETIN (PREALBUMIN) COMPLEX WITH FLUFENAMIC ACID (2-3-(TRIFLUOROMETHYL)PHENYL AMINO BENZOIC ACID)

• 1bmz: HUMAN TRANSTHYRETIN (PREALBUMIN)

  1bmz: HUMAN TRANSTHYRETIN (PREALBUMIN)

• 1bz8: TRANSTHYRETIN (DEL VAL122)

  1bz8: TRANSTHYRETIN (DEL VAL122)

• 1bzd: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

  1bzd: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

• 1bze: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

  1bze: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

• 1dvq: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN

  1dvq: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN

• 1dvs: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL

  1dvs: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH RESVERATROL

• 1dvt: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN

  1dvt: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH FLURBIPROFEN

• 1dvu: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACID

  1dvu: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DIBENZOFURAN-4,6-DICARBOXYLIC ACID

• 1dvx: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC

  1dvx: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH DICLOFENAC

• 1dvy: CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID

  1dvy: CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID

• 1dvz: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O-TRIFLUOROMETHYLPHENYL ANTHRANILIC ACID

  1dvz: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN IN COMPLEX WITH O-TRIFLUOROMETHYLPHENYL ANTHRANILIC ACID

• 1e3f: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING

  1e3f: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING

• 1e4h: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING

  1e4h: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING

• 1e5a: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING

  1e5a: STRUCTURE OF HUMAN TRANSTHYRETIN COMPLEXED WITH BROMOPHENOLS: A NEW MODE OF BINDING

• 1eta: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

  1eta: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

• 1etb: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

  1etb: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

• 1f41: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT 1.5A RESOLUTION

  1f41: CRYSTAL STRUCTURE OF HUMAN TRANSTHYRETIN AT 1.5A RESOLUTION

• 1f86: TRANSTHYRETIN THR119MET PROTEIN STABILISATION

  1f86: TRANSTHYRETIN THR119MET PROTEIN STABILISATION

• 1fh2: TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS

  1fh2: TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS

• 1fhn: TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS

  1fhn: TRANSTHYRETIN STABILITY AS A KEY FACTOR IN AMYLOIDOGENESIS

• 1g1o: CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETIN MUTANT TTR G53S/E54D/L55S

  1g1o: CRYSTAL STRUCTURE OF THE HIGHLY AMYLOIDOGENIC TRANSTHYRETIN MUTANT TTR G53S/E54D/L55S

• 1gko: AN ENGINEERED TRANSTHYRETIN MONOMER THAT IS NON-AMYLOIDOGENIC - UNLESS PARTIALLY DENATURED

  1gko: AN ENGINEERED TRANSTHYRETIN MONOMER THAT IS NON-AMYLOIDOGENIC - UNLESS PARTIALLY DENATURED

• 1ict: MONOCLINIC FORM OF HUMAN TRANSTHYRETIN COMPLEXED WITH THYROXINE (T4)

  1ict: MONOCLINIC FORM OF HUMAN TRANSTHYRETIN COMPLEXED WITH THYROXINE (T4)

• 1iii: CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT ROOM TEMPERATURE

  1iii: CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT ROOM TEMPERATURE

• 1iik: CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT CRYO TEMPERATURE

  1iik: CRYSTAL STRUCTURE OF THE TRANSTHYRETIN MUTANT TTR Y114C-DATA COLLECTED AT CRYO TEMPERATURE

• 1ijn: Crystal structure of the transthyretin mutant TTR C10A/Y114C

  1ijn: Crystal structure of the transthyretin mutant TTR C10A/Y114C

• 1qab: The structure of human retinol binding protein with its carrier protein transthyretin reveals interaction with the carboxy terminus of RBP

  1qab: The structure of human retinol binding protein with its carrier protein transthyretin reveals interaction with the carboxy terminus of RBP

• 1qwh: a covalent dimer of transthyretin that affects the amyloid pathway

  1qwh: a covalent dimer of transthyretin that affects the amyloid pathway

• 1rlb: RETINOL BINDING PROTEIN COMPLEXED WITH TRANSTHYRETIN

  1rlb: RETINOL BINDING PROTEIN COMPLEXED WITH TRANSTHYRETIN

• 1sok: Crystal structure of the transthyretin mutant A108Y/L110E solved in space group p21212

  1sok: Crystal structure of the transthyretin mutant A108Y/L110E solved in space group p21212

• 1soq: Crystal structure of the transthyretin mutant A108Y/L110E solved in space group C2

  1soq: Crystal structure of the transthyretin mutant A108Y/L110E solved in space group C2

• 1tha: MECHANISM OF MOLECULAR RECOGNITION. STRUCTURAL ASPECTS OF 3,3'-DIIODO-L-THYRONINE BINDING TO HUMAN SERUM TRANSTHYRETIN

  1tha: MECHANISM OF MOLECULAR RECOGNITION. STRUCTURAL ASPECTS OF 3,3'-DIIODO-L-THYRONINE BINDING TO HUMAN SERUM TRANSTHYRETIN

• 1thc: CRYSTAL STRUCTURE DETERMINATION AT 2.3A OF HUMAN TRANSTHYRETIN-3',5'-DIBROMO-2',4,4',6-TETRA-HYDROXYAURONE COMPLEX

  1thc: CRYSTAL STRUCTURE DETERMINATION AT 2.3A OF HUMAN TRANSTHYRETIN-3',5'-DIBROMO-2',4,4',6-TETRA-HYDROXYAURONE COMPLEX

• 1tlm: STRUCTURAL ASPECTS OF INOTROPIC BIPYRIDINE BINDING: CRYSTAL STRUCTURE DETERMINATION TO 1.9 ANGSTROMS OF THE HUMAN SERUM TRANSTHYRETIN-MILRINONE COMPLEX

  1tlm: STRUCTURAL ASPECTS OF INOTROPIC BIPYRIDINE BINDING: CRYSTAL STRUCTURE DETERMINATION TO 1.9 ANGSTROMS OF THE HUMAN SERUM TRANSTHYRETIN-MILRINONE COMPLEX

• 1tsh: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

  1tsh: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

• 1tt6: The orthorhombic crystal structure of transthyretin in complex with diethylstilbestrol

  1tt6: The orthorhombic crystal structure of transthyretin in complex with diethylstilbestrol

• 1tta: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

  1tta: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

• 1ttb: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

  1ttb: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

• 1ttc: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

  1ttc: THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL30MET VARIANT TO 1.7 ANGSTROMS RESOLUTION

• 1ttr: TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANT

  1ttr: TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANT

• 1tyr: TRANSTHYRETIN COMPLEX WITH RETINOIC ACID

  1tyr: TRANSTHYRETIN COMPLEX WITH RETINOIC ACID

• 1tz8: The monoclinic crystal structure of transthyretin in complex with diethylstilbestrol

  1tz8: The monoclinic crystal structure of transthyretin in complex with diethylstilbestrol

• 1u21: transthyretin with tethered inhibitor on one monomer.

  1u21: transthyretin with tethered inhibitor on one monomer.

• 1x7s: The X-ray crystallographic structure of the amyloidogenic variant TTR Tyr78Phe

  1x7s: The X-ray crystallographic structure of the amyloidogenic variant TTR Tyr78Phe

• 1x7t: Structure of TTR R104H: a non-amyloidogenic variant with protective clinical effects

  1x7t: Structure of TTR R104H: a non-amyloidogenic variant with protective clinical effects

• 1y1d: Crystal structure of transthyretin in complex with iododiflunisal

  1y1d: Crystal structure of transthyretin in complex with iododiflunisal

• 1z7j: Human transthyretin (also called prealbumin) complex with 3, 3',5,5'-tetraiodothyroacetic acid (t4ac)

  1z7j: Human transthyretin (also called prealbumin) complex with 3, 3',5,5'-tetraiodothyroacetic acid (t4ac)

• 1zcr: Crystal structure of human Transthyretin with bound iodide

  1zcr: Crystal structure of human Transthyretin with bound iodide

• 1zd6: Crystal structure of human transthyretin with bound chloride

  1zd6: Crystal structure of human transthyretin with bound chloride

• 2b14: The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Leu 55 Pro

  2b14: The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Leu 55 Pro

• 2b15: The crystal structure of 2,4-dinitrophenol in complex with human transthyretin

  2b15: The crystal structure of 2,4-dinitrophenol in complex with human transthyretin

• 2b16: The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Tyr78Phe

  2b16: The crystal structure of 2,4-dinitrophenol in complex with the amyloidogenic variant Transthyretin Tyr78Phe

• 2b77: Human transthyretin (TTR) complexed with Diflunisal analogues- TTR.2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID

  2b77: Human transthyretin (TTR) complexed with Diflunisal analogues- TTR.2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID

• 2b9a: Human transthyretin (TTR) complexed with diflunisal analogues- TTR.3',5'-difluorobiphenyl-4-carboxylic acid

  2b9a: Human transthyretin (TTR) complexed with diflunisal analogues- TTR.3',5'-difluorobiphenyl-4-carboxylic acid

• 2f7i: Human transthyretin (TTR) complexed with diflunisal analogues- TTR. 2',6'-Difluorobiphenyl-4-carboxylic Acid

  2f7i: Human transthyretin (TTR) complexed with diflunisal analogues- TTR. 2',6'-Difluorobiphenyl-4-carboxylic Acid

• 2f8i: Human transthyretin (TTR) complexed with Benzoxazole

  2f8i: Human transthyretin (TTR) complexed with Benzoxazole

• 2fbr: Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (4 carbon linker)

  2fbr: Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (4 carbon linker)

• 2flm: Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (6 carbon linker)

  2flm: Human transthyretin (TTR) complexed with bivalant amyloid inhibitor (6 carbon linker)

• 2g3x: Crystal structure of Transthyretin mutant I84S at acidic pH

  2g3x: Crystal structure of Transthyretin mutant I84S at acidic pH

• 2g3z: Crystal structure of Transthyretin mutant I84A at low pH

  2g3z: Crystal structure of Transthyretin mutant I84A at low pH

• 2g4e: Crystal structure of transthyretin mutant I84A at neutral pH

  2g4e: Crystal structure of transthyretin mutant I84A at neutral pH

• 2g4g: Crystal structure of human transthyretin at pH 4.6

  2g4g: Crystal structure of human transthyretin at pH 4.6

• 2g5u: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4,4'-dihydroxy-3,3',5,5'-tetrachlorobiphenyl

  2g5u: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4,4'-dihydroxy-3,3',5,5'-tetrachlorobiphenyl

• 2g9k: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-2',3,3',4',5-Pentachlorobiphenyl

  2g9k: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-2',3,3',4',5-Pentachlorobiphenyl

• 2gab: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-3,3',5,4'-tetrachlorobiphenyl

  2gab: Human Transthyretin (TTR) Complexed with Hydroxylated polychlorinated Biphenyl-4-hydroxy-3,3',5,4'-tetrachlorobiphenyl

• 2h4e: Crystal structure of Cys10 sulfonated transthyretin

  2h4e: Crystal structure of Cys10 sulfonated transthyretin

• 2noy: Crystal structure of transthyretin mutant I84S at PH 7.5

  2noy: Crystal structure of transthyretin mutant I84S at PH 7.5

• 2pab: STRUCTURE OF PREALBUMIN, SECONDARY, TERTIARY AND QUATERNARY INTERACTIONS DETERMINED BY FOURIER REFINEMENT AT 1.8 ANGSTROMS

  2pab: STRUCTURE OF PREALBUMIN, SECONDARY, TERTIARY AND QUATERNARY INTERACTIONS DETERMINED BY FOURIER REFINEMENT AT 1.8 ANGSTROMS

• 2rox: TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4)

  2rox: TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4)

• 2roy: TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5'-DINITRO-N-ACETYL-L-THYRONINE

  2roy: TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH 3',5'-DINITRO-N-ACETYL-L-THYRONINE

• 2trh: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

  2trh: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

• 2try: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

  2try: TERTIARY STRUCTURES OF THREE AMYLOIDOGENIC TRANSTHYRETIN VARIANTS AND IMPLICATIONS FOR AMYLOID FIBRIL FORMATION

• 5ttr: LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTURE

  5ttr: LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTURE